Overview

Intravenous (IV) Versus Oral Iron Treatment of Iron Deficiency Anemia in the Post-operative Bariatric Surgical Patient

Status:
Withdrawn
Trial end date:
2022-09-01
Target enrollment:
Participant gender:
Summary
The aim of the study is to compare two accepted treatments for iron deficiency anemia (oral ferrous sulfate and intravenous ferumoxytol) for efficacy and speed of response in the treatment of iron deficiency anemia (IDA) in the post-operative bariatric surgical patient. In this study, 104 bariatric surgical post-operative patients will be randomly assigned 52 each to oral or 52 to a single dose IV iron treatment using double-blind procedures.
Phase:
N/A
Details
Lead Sponsor:
Johns Hopkins University
Collaborator:
AMAG Pharmaceuticals, Inc.
Treatments:
Ascorbic Acid
Ferrosoferric Oxide
Iron
Vitamins